CLDN4 and pancreatic neoplasm: In another study, Patrick Michl and his team demonstrated that claudin-4 could suppress invasiveness and the metastatic phenotype of pancreatic cancer cells through the TGF-β and Ras signaling pathways (Michl 2003).